chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer-BioNTech COVID-19 Vaccine EUA   Diagnosed with Bell?s palsy.
Started with a runny nose and post nasal drip and coughing, I had just flown back home and originally thought it was my allergies starting up as soon as I got home. I coughed through the night and all the next day, which was Sunday. I coughed so much my ribs hurt, and the runny nose just wouldn't stop. I took some cough and cold medicine but it didn't really work. Monday I developed a low grade fever, the highest was 100.8 F. I took a home test and tested positive for COVID-19. Then I texted with my doctor, she said to go in the morning to the ER and ask for the monoclonal antibodies treatment. At that point my husband was still negative. We went at about 5:30 in the AM on Tuesday and my husband tested positive at that time. He never got sick, but we both received the MAB treatment. The overall time period was about a week. It was pretty mild, I never got too sick.
Information has been received from licensed practical nurse concerning a 77 year old male (weight 139#) with a history of stroke and blood pressure high who on 07-NOV-2006 was vaccinated with the first dose of Pneumovax 23 (lot #0985F/655291), 0.5 ml, IM.  Concomitant medication was not reported.  On 07-NOV-2006, the patient experienced local redness and swelling from her shoulder to elbow after vaccination with Pneumovax 23.  The patient was treated with cold compresses and TYLENOL.  On 09-NOV-2006 seventy-two hours after injection, the patient recovered from local redness and swelling from her shoulder to elbow.  The events were considered to be non-serious.  Additional information is not expected.
Extremely minor allergic reaction to injection. Within minutes of injection I had a red butterfly shaped fash in my cheeks. The rash was very warm to the touch and my face felt warm in general. I developed no further symptoms of an allergic reaction, and the rash went away within 2 hours untreated.
Initial report received from a health care provider on 27/Mar/2006. A five-year-old patient (gender not reported) had received an intramuscular, right arm injection of Daptacel, lot number number C2405AA, on 22/Mar/2006. Two days later, the patient experienced "redness and swelling of the entire arm after vaccination". The patient had received four previous doses. At the time of this report the patient had recovered from the event. The reporter in this case is the same as for 2006-00694, 2006-00695, 2006-00693, 2006-00697, 2006-00698, 2006-00699, and 2006-00700.
Patient given ActHib (Lot UJ176AA (deltoid with sterile water (Merck sterile diluent Lot S025290) vs. 0.41% saline. Per Sanofi Pasteur (Manufacturer), dose needs to be reported. No additional adverse reactions are expected. Mother informed. Replacement dose scheduled minimum 4 wk interval.
Caller reported administration of PROQUAD after product experienced temperature excursion; This spontaneous report was received from a medical assistant referring to a 4-year-old female patient. The patient's historical condition, concomitant drugs and allergy to drugs were not reported.   On 06-OCT-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) ( lot number was T015598, expiration dare was 02-NOV-2021, dose, strength were not reported) subcutaneously in the left vastus lateralis for prophylaxis (Product storage error). Other suspect therapies included diphtheria toxoid, pertussis acellular 3-component vaccine, poliovirus vaccine inactivated (vero), tetanus toxoid(KINRIX) (lot number was PP9L5, expiration dare was 16-OCT-2021, dose, strength were not reported ).      Temperature excursion of this vaccine was 15 degrees Fahrenheit to 46 degrees Fahrenheit for 2 hours and 19 minutes without any previous temperature excursion. The digital data logger which was involved in recording excursion details (also reported no data logger was involved). The patient was fine.
Headache, runny nose, sore arm within 12hrs. Diarrhea day 3 after the shot.
No additional AE information provided; the patient was administered an improperly stored dose of PEDVAXHIB; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 02-JAN-2020, the patient was vaccinated an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (PEDVAXHIB) (lot# S007079, expiration date 24-JAN-2022; dose and route were unknown) for prophylaxis (product storage error).   Temperature excursion of this vaccine was 8.64 Celsius degrees for 30 minutes. There was no previous temperature excursion. No additional adverse event was reported. Data logger was involved.
it was hot; it was very itchy; rash at the injection site that was quite large about 3 to 5 inches; it was red; it was swollen; typical soreness; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE WARMTH (it was hot), VACCINATION SITE PRURITUS (it was very itchy), MYALGIA (typical soreness), VACCINATION SITE RASH (rash at the injection site that was quite large about 3 to 5 inches) and VACCINATION SITE ERYTHEMA (it was red) in a 73-year-old female patient who received COVID-19 VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy. Concomitant products included ESTRADIOL for HRT.   On 08-Jan-2021, the patient received first dose of COVID-19 VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE) (Intramuscular) dosage was changed to 1 dosage form at an unspecified frequency. On an unknown date, the patient received first dose of COVID-19 VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE) (Intramuscular) 1 dosage form at an unspecified frequency. On 08-Jan-2021,  after starting COVID-19 VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE), the patient experienced MYALGIA (typical soreness). On 15-Jan-2021, the patient experienced VACCINATION SITE WARMTH (it was hot), VACCINATION SITE PRURITUS (it was very itchy), VACCINATION SITE RASH (rash at the injection site that was quite large about 3 to 5 inches), VACCINATION SITE ERYTHEMA (it was red) and VACCINATION SITE SWELLING (it was swollen). On 31-Jan-2021, VACCINATION SITE WARMTH (it was hot) had resolved. At the time of the report, VACCINATION SITE PRURITUS (it was very itchy), MYALGIA (typical soreness), VACCINATION SITE RASH (rash at the injection site that was quite large about 3 to 5 inches), VACCINATION SITE ERYTHEMA (it was red) and VACCINATION SITE SWELLING (it was swollen) outcome was unknown.            con meds: Progesterone, 1mg, oral route, HRT-indication Patient have medication allergy, Ibuprofen allergy, Augmentin allergy, but not allergic to other penicillin's.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up received: Please confirm NNI
Pt recvd 2nd dose of Hep B vax 27FEB92 & on 28FEB92 & exp a h/a, stiff neck, shoulder pain, swelling of arm, generalized achiness & stiffness; tx APAP & pt recovered in approx 2 days; no further details were provided;
Pt seen on 2/24/2021 for vaccine reaction, initial encounter, acute gastroenteritis, chest pain, unspecified type; GI s/s following COVID vaccination and 4 days of chest pain, cardiac workup negative, MD felt overall may be from recent GI Illness causing chest pain, IV's given and antiemetics, able to eat small amount of food here in ER, discharged home, close follow up with PCP and cardiology, concerned over possible COVID - tested and negative in ER, shortly after COVID vaccine began to have nausea, vomiting, diarrhea, inter. stomach cramping, sensitive stomach, past 4 days chest heaviness and pain around heart, cardiac history in past.  To follow up with APNP ASAP.
pt (exact # unk) exp local rxn such as redness, swelling, & pain @ the inj site upon receiving vax in OCT95;
Information has been received from a licensed practical nurse referring to multiple unspecified patients of unknown age and gender. Information regarding the concurrent condition or medical history was unknown. On unknown dates, the patients were each vaccinated with a dose of improperly stored VAQTA (lot # reported as N005796 with expiration date 26-MAY-2018, lot # reported as N012324 with expiration date 05-APR-2018) (dose and route unknown) for prophylaxis. No adverse events were reported. The vaccines were stored under 0-1 degrees Celsius for 3 hours and 43 minutes and 9-25 degrees Celsius for 3 hours and 4 minutes. Data logger was involved. This is one of several report received from the same reporter. Sender's Comments: US-009507513-1707USA010619: US-009507513-1707USA010872.
Excruciating headache, dry mouth and eyes, Nausea and vomiting
Site: Pain at Injection Site-Mild, Systemic: she heard a pop during injection-Mild, Additional Details: patient did not receive full dose of vaccine as she jumped out of chair during vaccination and needle came out of arm. she received only part of the dose and she said she heard a pop.  she immediatelyleft the pharmacy . pharmacist asked her to stay for 15minutes and patient refused.
Developed papular rash over entire body later on 08-06-09.  No itching with rash.  No redness, swelling or inflammation noted at injection sites.  Benadryl given on 08-09-09 which diminished the appearance of the rash.
Periorbital erythema, yellow conjunctival discharge, normal sclera - reaction after both doses of flu.
Red lump 0.5 inches on anteromedial edge of axilla, Painful to touch and raise right arm; Red lump 0.5 inches on anteromedial edge of axilla, Painful to touch and raise right arm; Firm palpitation; This is a spontaneous report from a non-contactable other Health Professional (patient). A 30-year-old non pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EK5730) via intramuscularly, administered in left arm on 19Jan2021 (at the age of 30-year-old) as single dose for covid-19 immunization. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, patient had not tested for COVID-19. The patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) on an unspecified date as a single dose for Covid-19 immunization. On 26Jan2021, the patient experienced red lump 0.5 inches on anteromedial edge of axilla, painful to touch and raise right arm and Firm palpitation. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
One week after vaccination developed elevated itchy rash about 3 inches in diameter has persisted for 6 days
screaming x 6 hrs (high pitched); agitated; fever 99.8 R;
I received flu shot from pharmacy 10/17/13 on Rt. arm and soon after injection, Rt arm became extremely red and sore. As day progressed my wife and I both with the same injection, we became more sore, redness, hot. We went to Med Ctr Sat. Oct 19, 2013. In hospital, no tests taken but ER physician noted extreme redness, heat, pain at site and black and blue mark at flu injection site.
herpes zoster; Information has been received regarding a case in litigation from a lawyer, and a female patient of unknown age.  No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On an unknown date in 2010, at age approximately 62, the patient was administered the zoster vaccine live (ZOSTAVAX) by a healthcare provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a healthcare provider for the following injury resulting from his zoster vaccine live (ZOSTAVAX) use: Herpes zoster. The patient claimed damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the herpes zoster is unknown.  Additional information has been requested.
1 week after receiving injection, patient developed a large erythematous area where the injection was given, the area is also warm to palpation. She did not receive the injection at my office.
Fever; injection site mild pain; This is a spontaneous report from a non-contactable other healthcare professional (patient) via a Pfizer sales representative. A 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. There were no medical history. Concomitant medications were not reported. The patient experienced fever and injection site mild pain on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 03-OCT-2011, the patient was administered with a dose of VARIVAX (Merck) (Lot # 0345AA expiry date unknown) (Route, dosing regimen and frequency unknown) which was exposed to a temperature excursion of up to -3 degrees Centigrade. No adverse events were reported. No product quality issue was reported. This is one of 121 reports received from the same source. Additional information has been requested.
pt recvd vax; devel cough w/ sputum which became green in color; devel chest pain assoc w/ it; after 5 days, pt hosp for numerous problems;  MD attributed to a "bacterial infect that is going around";
Mild fatigue; Queasiness; Low fever; This non-serious case was reported by a consumer via call center representative and described the occurrence of fatigue in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis  On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fatigue (Verbatim: Mild fatigue), queasy (Verbatim: Queasiness) and fever (Verbatim: Low fever). The outcome of the fatigue, queasy and fever were not reported.  It was unknown if the reporter considered the fatigue, queasy and fever to be related to Shingrix.  It was unknown if the company considered the fatigue, queasy and fever to be related to Shingrix.  Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by the patient via call center.  The patient stated that the she was just wondering how long side effects of the shot would be lasted.  She had mild fatigue, queasiness, and a low fever. Nothing terrible, just bleh. The reporter had consented to follow-up.
A day after the vaccine I got a bump and red. I took a pill for pain, I was tired. A week after my hip hurt and I called my job I could not work - I had the joint pain for 5 days. I had fever for 1 day - I went back to work. I saw the doctor 5/17  because my body hurt. They found out I had fibromyalgia.
Four days after I was given a Rubella vaccination my left shoulder began to have a severe pain, it spread to the middle of my back, neck, and down my arm. After a few days it was down my right arm and shoulder also. The pain was severe and I could hardly use my left arm at all. Nothing would help the pain. I tried a maximum dose of Ibuprophen, narcotic analgesics, ice, heat, arthritis "rub", hot showers, nothing even helped it at all. After about 3 weeks the pain finally subsided only to return every single time I exercise at anything more than a light effort. The pain is not as severe most of the time when it returns but it keeps coming back and can be severe at times. I have tried most over the counter drugs that are safe while breastfeeding (the vaccine was given to me immediately after giving birth) but none seem to work. I have gone to a chiropractor and that didn't work either.
redness & erythema @ injection site. Progressive since onset.  Ibuprofen OTC only.
On 6-7-2022, I started having a scratchy throat, brain fog, fatigue, possible fever (did not check) and upper respiratory congestion. It got worse overnight. The next day, I took a Covid home test and it was positive. On 6-9, I took another home Covid test and it was positive as well. I went to the walk in public clinic that day and they gave me a steroid injection and antiviral injection as well as a zpac and cough syrup. I am better today and I am reporting a breakthru case of Covid.
Around 4 pm the day after receiving a COVID vaccine patient started getting tired, fatigue, headache, and feeling hot. At 7:00 pm on Sunday with bottom lip swelling. Monday eyelid swelling. No itching. Benadryl 25 mg given in office.
Received Pfizer covid vaccine #1 on 2/17 at 0800. On 2/18 at 1100 AM I developed diffuse hives head to toe. No respiratory symptoms. Only known allergy is cefzil.
PATIENT FILLED OUT FORM TO GET MODERNA COVID-19 VACCINATION. TECHNICIAN MISSED SCREENING OF AGE AND GAVE 16 YEARS OLD MODERNA SHOT INSTEAD OF GIVING PFIZER ( WHICH IS APPROVED UNDER EUA FOR 16 YEARS AND OVER). AS SOON AS PHARMACIST IN-CHARGE DISCOVERED ERROR, TRIED CONTACTING PATIENT AND WAS ONLY SUCCESSFUL AFTER COUPLE DAYS.  UPON CONSULTATION PATIENT HAS NO SIDE EFFECTS AND WAS GIVEN DIRECT CONTACT NO TO CONTACT PHARMACY IN-CHARGE IN ANY ADVERSE EVENT AND ALSO TO CALL 911 FOR EMERGENCY. AT THIS POINT PATIENT HAS BEEN MONITORED FOR ANY UNUSUAL SYMPTOMS EVERY 5 DAYS.
"Pfizer-Bio-Tech COVID-19 Vaccine EUA" Individual came in Clinic for Covid-19 Vaccine. She began to itching and developed redness on her bilateral forearms and shins 5 mins. After receiving vaccine.    1:30 pm vitals were 137/88,89, 20, 98% SATS on RA. Individual stated she has a history of allergies. 1:35 PM 138/88, 90, 20.  Individual was given Benadryl 50 mg IM in right deltoid. Vitals at 1:50 pm were 140/90, 89, 20 98 % SATS RA itchy is less intense. At 2:10 pm vitals 140.90, 78, 20, 100% SATS RA with no noted acute distress, redness and itching has decreased in bilateral arms and legs. Individual was discharge home with family. Patient was advised to see allergist and get cleared before receiving second vaccine
site of inj was painful & began to swell & get hard;2hrs p/vax rt deltoid w/in 24hrs of redness & swelling had inc to the diameter of a softball;By 72 hrs, redness & swelling were decreasing but area of ecchymosis appeared & is resolving;
patient received booster dose of 0.25 ml moderna and experienced a drop in blood pressure (60/36) and was admitted to intensive care unit with difficulty breathing from 11-09 to 11-11, reported feeling better but slightly under the weather. as of 11-12 patient is reporting feeling almost back to normal.
Got Dizzy, Blood pressure Very high. June 3,2021 I felt Very Dizzy
Patient had injection on 3-5-2021 in L deltoid. Site warm - red & worsening pain. Evaluated on 3-12-2021 - redness measuring 6x6.6 cm & firm area 7x9cm in L deltoid - painful.  Cellulitis
Patient came in for second dose of Covid 19 Pfizer vaccine on September 21,2021 and reported that she felt a tingling sensation and pain in left hip and leg  soon after 1st dose. Patient also reported having upper back pain since the 1st dose also that has not gone away.
I am a Pediatrician and have a question regarding an erroneous administration, which happened at my office yesterday, as an honest mistake of the 15 mo. set of recommended Vaccines, namely, DtaP, HIB and Prevnar-13 to a child who had already received those at her actual 15 mo. of age in Dec. 2014. The child is an otherwise healthy child and I have spoken to the parents about what happened and will follow on any side-effects during the day tomorrow and am available to them in case of any adverse effect. The baby is doing well as of today as well except for slight fussiness per parents.
the patient was quite sick for 48 hours; chills; fatigue; muscle pain; nausea; vomiting/numerous episodes of vomiting; bad headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (the patient was quite sick for 48 hours), CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscle pain) and NAUSEA (nausea) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FLUOXETINE and LORAZEPAM for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscle pain), NAUSEA (nausea), VOMITING (vomiting/numerous episodes of vomiting), HEADACHE (bad headache) and PYREXIA (fever). On an unknown date, the patient experienced ILLNESS (the patient was quite sick for 48 hours). At the time of the report, ILLNESS (the patient was quite sick for 48 hours) was resolving and CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscle pain), NAUSEA (nausea), VOMITING (vomiting/numerous episodes of vomiting), HEADACHE (bad headache) and PYREXIA (fever) outcome was unknown.            No treatment medications were provided
Initial information was received on 01 December 2008 from a health care professional. A 32 year old female patient with a possible sulfa allergy received an intramuscular right deltoid injection (lot number unknown) on 27 October 2008. 48 hours post vaccination, the patient developed a rash that began on her lower extremities and had spread everywhere except for her face. She was treated with ATARAX, MEDROL, and PREDNISONE. The rash persisted despite treatment. The rash was described as red, slightly raised with an abrasion type feeling. She also complained of itching and burning. The patient was not recovered at the time of the report. List of Documents held by Sender: None.
Severe muscle pains and throat pain. No other symtoms. Went to hospital. Diagnized as Myositis.  12/07/09 ED notes received for DOS 11/30/09 and Vaccine records received for DOS 11/16/09: DX: myositis 12/8/2009 MR and labs for 11/30/2009 DC Dx Myositis    Pt presented to ED with c/o sore throat, and muscle aches BL in thighs. On examination: congestion, myalgias, oral lesions. tx: Motrin, Tamiflu. Pt improved and discharged home.
had the shot / still got the shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles in 2009).   On an unknown date, the patient received Shingles vaccine. On 17th December 2021, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was self-reported by the patient. The age at vaccination was not reported. The reporter stated that, he/she had the Shingles shot several years later and on the day of reporting in December 2021, the patient had still got the shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation regarding the shingles were unknown at the time of reporting.